Legal Representation
Attorney
Jennifer Kwon
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| May 12, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| May 12, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Oct 8, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 13, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 13, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 8, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 3, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 6, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Biological preparations for scientific use for use in gene therapy, gene editing, gene insertion, and cell therapy
Class 005
Pharmaceutical preparations and biological preparations for medical treatment for use in gene therapy, gene editing, gene insertion, and cell therapy for the treatment of genetic disorders; Pharmaceutical and biological preparations for the treatment of genetic disorders; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, modification, regulation, and repair for use in human therapeutics
Class 042
Medical and scientific research; Medical research and development in the fields of genomic medicine, genome engineering, and cell engineering; Scientific research and development in the field of genomic medicine, genome engineering, and cell engineering; Research and development of pharmaceutical preparations for gene therapy, gene editing, gene insertion, and cell therapy; Providing medical and scientific research information in the fields of genomic medicine, genome engineering, and cell engineering
Class 044
Providing medical and healthcare information in the field of gene sequencing, gene editing, and gene insertion technologies; Providing medical and healthcare information regarding gene therapies and cell therapies
Classification
International Classes
001
005
042
044
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO